Official Development Assistance Reductions: Higher Education

What recent discussions his Department has had with the Department for Business, Energy and Industrial Strategy on the effect of official development assistance funding reductions on (a) higher education research and (b) universities.

What recent discussions his Department has had with the Department for Business, Energy and Industrial Strategy on the effect of official development assistance funding reductions on (a) higher education research and (b) universities.

What recent discussions his Department has had with the Department for Business, Energy and Industrial Strategy on the effect of official development assistance funding reductions on (a) higher education research and (b) universities.

My Department and I regularly discuss research in universities in England with the Department for Business, Energy and Industrial Strategy and with the Minister for science, research and innovation, my hon. Friend the Member for Derby North (Amanda Solloway). Overall, Government investment in research and development across the UK is up to £14.9 billion in 2021-22, following four preceding years of significant growth. This shows the clear benefits of the Union in delivering on science and research across the nation.

The Universities of Glasgow, Leeds, Liverpool, Newcastle and Coventry have all been leaders in the global challenges research fund. With the cuts to ODA, they are now having to find additional seven-figure funding to keep life-saving research going. Is this really the Tories’ fabled levelling-up agenda?

The Government recognise the importance of supporting international research partnerships and the UK research sector, especially our universities. Our commitment to research and innovation was clearly demonstrated by the recent Budget announcement that we are increasing investment in research and development to £14.6 billion. International collaboration is central to a healthy and productive R&D sector and, as a result of the policies of this Government, UK scientists will have access to more public funding than ever before.

Twelve flagship research hubs were supposed to run projects lasting five to 10 years in support of the sustainable development goals. Some of those projects are midway through clinical trials on humans but, thanks to the recent cuts, might not be able to continue, thereby jeopardising both the research and research jobs. How on earth can the Government justify funding cuts to research projects in the middle of human clinical trials, in clear violation of medical ethics?

The hon. Gentleman might like to take up his question with the Department for Business, Energy and Industrial Strategy, which is ultimately responsible for research. On 1 April, BEIS set out an additional £250 million of funding for R&D—as a result of which, as I have said, UK scientists will have access to more public funding than ever before—taking the total Government investment in R&D to £14.9 billion in 2021-22, despite what the Opposition would have the public believe.

Because of the ODA cuts, universities have reported that research contracts have been terminated, sometimes with just a few hours’ notice. This has undermined trust between researchers, universities and UK Research and Innovation, and it also means that research commissioners now require a risk assessment on the UK Government’s ability to honour contracts. Why does the Minister think it is acceptable that the UK Government’s promises mean so little that they need to be risk assessed?

On the actual ODA allocations, BEIS is currently working with UKRI, all global challenge research funds and its Newton fund delivery partners to manage the financial year 2021-22, including by determining which projects will go ahead. Its delivery partners have been communicated with, and award holders will set out the next stages of the review of ODA funding next year and explore the options available for individual programmes.